SDF1-mediated CXCR4-internalization in NG108-15 cells. by Katrin Feldbauer (3234774)

“…The specific cell capacitance (slope of the linear fit) decreases in presence of SDF1α. <b>b.</b> Confocal laser scanning micrographs of NG108-15 cells expressing CXCR4::eYFP in the presence of the inhibitor AMD3100 or the agonist SDF1α as indicated. …”

Maximum concentrations (ng/L) of 88 pharmaceuticals detected at least once (in order of decreasing number of detections across all regions and samples) in water samples from wadeab... by Paul M. Bradley (523469)

TMD residues decrease sensitivity. by Ákos Nemecz (356830)

“…Glu residues are color coded based upon effect, with residues in red producing a significant decrease in pH₅₀, and in yellow, an insignificant or weak effect, whereas the dark purple and magenta for His residues are synonymous to the red of Glu residues. …”

Mean fecal egg count per individual before and after administration of a single oral dose albendazole. by Martin Walker (170282)

<i>In vitro</i> 95% CI lower and upper mean susceptibility responses of field isolates to antimalarials. by Winnie Okore (14139712)

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

Comparison of glucose consumption and lactate production in culture medium of HL-1 cells exposed to LG, NG, HG and IHG between short- (12h) and long-time (72h) glucose treatment. by Patrick Mordel (17020879)

Inhibition of ERK 1/2 decreases GM-CSF- and IL-3-responsive Eo/B CFU, but not IL-5-responsive colonies. by Pia Reece (589971)

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

rHPL binding signals to glycans on CFG array v5.1. by Sim-Kun Ng (495657)

Fig 5 - by Jie He (132999)

Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Subjects:

Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Subjects:

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 1. by Rahsan Erdem (11726357)

Subjects:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Subjects: